Paper39299261
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
GBD 2021 Antimicrobial Resistance Collaborators. Lancet, 2024. Cited by 2,884 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Papers, record 39299261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39299261
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Global Health | Major topic |
| Anti-Bacterial Agents | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Bacterial Infections | Major topic |
| Forecasting | Major topic |
| Humans | |
| Disability-Adjusted Life Years | |
| Aged | |
| Infant | |
| Child, Preschool | |
| Child | |
| Middle Aged | |
| Adult | |
| Adolescent | |
| Male | |
| Female |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | PubMed | ||
| K23 GM141463 | NIGMS NIH HHS | United States | K23GM141463 | PubMed | NIH RePORTER |
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT06695832 | Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia | Background | ClinicalTrials.gov | |
| NCT07167173 | Predictive Model for Multidrug Resistance in Patients Admitted to the Emergency Department With Sepsis | Background | ClinicalTrials.gov | |
| NCT07619924 | Randomized Controlled Study on the Safety and Efficacy of Phage Cocktail in the Treatment of Multidrug-Resistant Bacterial Skin Infections | Background | ClinicalTrials.gov | |
| NCT07797569 | Prevalence of Multidrug-Resistant Organism Infections in General Adult Wards in Argentina (PREV-AR 2 - IGA) | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 39,299,259 | Global burden of antimicrobial resistance and forecasts to 2050. | https://conductscience.org/library/papers/39299259 |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,762,325 | Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38762325 | PubMed |
| 2 | 38,582,094 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38582094 | PubMed |
| 3 | 35,065,702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
| 4 | 37,727,594 | The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis. | Lancet Reg Health Am | 2023 | https://conductscience.org/library/papers/37727594 | PubMed |
| 5 | 37,160,867 | The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria. | Nat Commun | 2023 | https://conductscience.org/library/papers/37160867 | PubMed |
| 6 | 28,903,154 | Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. | JAMA | 2017 | https://conductscience.org/library/papers/28903154 | PubMed |
| 7 | 37,381,690 | SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update. | Infect Control Hosp Epidemiol | 2023 | https://conductscience.org/library/papers/37381690 | PubMed |
| 8 | 38,797,178 | Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance. | Lancet | 2024 | https://conductscience.org/library/papers/38797178 | PubMed |
| 9 | 37,139,824 | American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. | J Am Geriatr Soc | 2023 | https://conductscience.org/library/papers/37139824 | PubMed |
| 10 | 38,797,179 | Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach. | Lancet | 2024 | https://conductscience.org/library/papers/38797179 | PubMed |
| 11 | 18,949,641 | Multimorbidity in primary care: prevalence and trend over the last 20 years. | Eur J Gen Pract | 2008 | https://conductscience.org/library/papers/18949641 | PubMed |
| 12 | 35,065,769 | Antimicrobial resistance: time to repurpose the Global Fund. | Lancet | 2022 | https://conductscience.org/library/papers/35065769 | PubMed |
| 13 | 26,407,352 | Systematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries. | J Pediatric Infect Dis Soc | 2015 | https://conductscience.org/library/papers/26407352 | PubMed |
| 14 | 36,423,648 | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. | Lancet | 2022 | https://conductscience.org/library/papers/36423648 | PubMed |
| 15 | 26,903,338 | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | JAMA | 2016 | https://conductscience.org/library/papers/26903338 | PubMed |
| 16 | 11,445,675 | Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. | Crit Care Med | 2001 | https://conductscience.org/library/papers/11445675 | PubMed |
| 17 | 34,473,285 | Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/34473285 | PubMed |
| 18 | 16,447,117 | The epidemiology and control of Acinetobacter baumannii in health care facilities. | Clin Infect Dis | 2006 | https://conductscience.org/library/papers/16447117 | PubMed |
| 19 | 36,209,761 | Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. | Lancet Glob Health | 2022 | https://conductscience.org/library/papers/36209761 | PubMed |
| 20 | 38,705,262 | Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps. | Pharmacol Res | 2024 | https://conductscience.org/library/papers/38705262 | PubMed |
Cited by2,263
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,884 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,985,343 | Microbiological Profile and Antimicrobial Resistance Patterns Among Orthopedic Patients at a Tertiary Care Centre in Uttarakhand, India. | Cureus | 2026 | https://conductscience.org/library/papers/42985343 | PubMed |
| 42,985,334 | From genome to phenotype: advances, challenges and One Health perspectives in the genomic prediction of antimicrobial resistance. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42985334 | PubMed |
| 42,985,202 | Shared resistome and mobilome signatures across One Health Escherichia coli sources. | Front Bioinform | 2026 | https://conductscience.org/library/papers/42985202 | PubMed |
| 42,985,086 | Mucin-rich environment shapes Pseudomonas aeruginosa cytotoxicity and phage-mediated epithelial protection. | iScience | 2026 | https://conductscience.org/library/papers/42985086 | PubMed |
| 42,984,548 | Genomic surveillance uncovers high-risk resistance profiles in Escherichia coli and Klebsiella spp. from Central Mexico. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42984548 | PubMed |
| 42,983,860 | Chicken farming may influence the gut antibiotic resistome and microbiome of workers: a metagenomic analysis. | Anim Microbiome | 2026 | https://conductscience.org/library/papers/42983860 | PubMed |
| 42,983,586 | More high-risk patients but stable levels of healthcare-associated infections and antibiotic use: findings from national point prevalence survey conducted in 2017 and 2022 in the Paris region hospitals. | Antimicrob Resist Infect Control | 2026 | https://conductscience.org/library/papers/42983586 | PubMed |
| 42,983,318 | Genomic and molecular insights into AMR, virulence, and toxin of Shiga toxin-producing Escherichia coli isolated from local curd foodborne outbreak in Manipur. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42983318 | PubMed |
| 42,983,286 | Diagnostic utility of plasma heparin-binding protein and procalcitonin among patients with bacterial infections: a single-center retrospective study. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42983286 | PubMed |
| 42,977,332 | Silent Contaminants: Antibiotic-Resistant Bacteria in Food Systems. | Microbiologyopen | 2026 | https://conductscience.org/library/papers/42977332 | PubMed |
| 42,975,948 | Benchmarking nanopore-based strategies for antimicrobial resistance prediction. | Microb Genom | 2026 | https://conductscience.org/library/papers/42975948 | PubMed |
| 42,974,914 | Patterns and potential indications of WHO AWaRe Watch antibiotic use across UK community and hospital care: a national observational study. | Eur J Public Health | 2026 | https://conductscience.org/library/papers/42974914 | PubMed |
| 42,974,318 | Macrophages as orchestrators of gut-organ axis crosstalk: immunometabolic reprogramming and host-directed therapy in sepsis. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42974318 | PubMed |
| 42,973,571 | CIT8, a machine learning-optimized antimicrobial peptide, exhibits potent activity against carbapenem-resistant Acinetobacter baumannii. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42973571 | PubMed |
| 42,966,920 | Modelling the transmission and burden of ESBL-producing Enterobacterales from a One Health perspective in Singapore. | One Health | 2026 | https://conductscience.org/library/papers/42966920 | PubMed |
| 42,964,472 | High-risk ARGs in environmental E. coli from the Taihu Lake watershed. | iScience | 2026 | https://conductscience.org/library/papers/42964472 | PubMed |
| 42,964,451 | Guideline Concordance of Antibiotic Recommendations From Large Language Models in Dentistry: A Vignette-Based Evaluation in Georgian and English. | Cureus | 2026 | https://conductscience.org/library/papers/42964451 | PubMed |
| 42,964,342 | Integrated in vitro and in silico assessment of antimicrobial, chemical antioxidant, and cytotoxic activities of endophytic Aspergillus sp. GK1 isolated from Mentha spicata roots. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42964342 | PubMed |
| 42,964,254 | Occurrence and molecular characteristics of carbapenem-resistant Enterobacteriaceae recovered from wildlife: a systematic review and meta-analysis. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42964254 | PubMed |
| 42,962,024 | A dual-targeting lipid nanoparticle delivery system for precision phage therapy against multidrug-resistant Gram-negative bacteria. | Sci Adv | 2026 | https://conductscience.org/library/papers/42962024 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39299261
GET https://conductscience.org/api/papers/v1/39299261/references?page=2